Finance
Ophthalmology company announces secondary offering
Published in Drug Week, June 25th, 2004
In addition, the selling stockholders have granted the underwriters a 30-day over-allotment option to purchase up to an additional 579,000 shares. All of the shares are being sold by selling stockholders. Eyetech will not sell any shares in, or receive any proceeds from, the offering.
The joint book-running managers of the offering are Merrill Lynch & Co. and Morgan Stanley, and Bear, Stearns & Co., Inc., is acting as co-manager.
Copies of the final prospectus relating to this offering...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-06-25)
More Articles from Drug Week
- Asthma
Clinical trial to evaluate Xolair in pediatric allergic asthma patients - Breast Cancer
Chemotherapy including epirubicin may improve survival for some patients - Non-Hodgkin Lymphoma
FDA accepts Onco TCS new drug application - Pneumonia
FDA approves Avelox (moxifloxacin HCI) for community-acquired pneumonia - AIDS Vaccine
Volunteers needed as more AIDS vaccines move into clinical trials - Adverse Drug Effects
Lupus-like syndrome linked to simvastin therapy - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
